Preface |
|
xiv | |
Acknowledgments |
|
xv | |
Abbreviations and Conversions |
|
xvi | |
|
|
|
Antibacterials, Beta-lactam |
|
|
|
Amoxicillin + clavulanic acid |
|
|
11 | (14) |
|
|
25 | (1) |
|
|
26 | (2) |
|
|
28 | (1) |
|
|
29 | (40) |
|
|
69 | (95) |
|
|
164 | (6) |
|
|
170 | (33) |
|
Ticarcillin disodium + clavulanate potassium |
|
|
203 | |
|
Antibacterials, Fluoroquinolones |
|
|
|
Ciprofloxacin hydrochloride |
|
|
38 | (32) |
|
Difloxacillin hydrochloride |
|
|
70 | (8) |
|
|
78 | (55) |
|
Marbofloxacin hydrochloride |
|
|
133 | (20) |
|
|
153 | (7) |
|
|
160 | (1) |
|
|
161 | (15) |
|
|
176 | |
|
Antibacterials, Lincosamides |
|
|
|
Clindamycin hydrochloride/palmitate |
|
|
43 | (81) |
|
|
124 | |
|
Antibacterials, Macrolides |
|
|
|
|
20 | (19) |
|
|
39 | (42) |
|
|
81 | (82) |
|
Antibacterials, Potentiated Sulfonamides |
|
|
|
Ormetoprim + sulfadimethoxine |
|
|
163 | (30) |
|
Sulfadiazine/sulfamethoxazole + trimethoprim |
|
|
193 | (2) |
|
|
195 | |
|
Antibacterials, Tetracyclines |
|
|
|
|
76 | (70) |
|
Minocycline hydrochloride |
|
|
146 | (53) |
|
Tetracycline hydrochloride |
|
|
199 | |
|
Antibacterials, Miscellaneous |
|
|
|
Chloramphenicol/chloramphenicol palmitate |
|
|
34 | (11) |
|
|
45 | (17) |
|
|
62 | (23) |
|
|
85 | (96) |
|
|
181 | |
|
|
|
|
13 | (10) |
|
|
23 | (66) |
|
|
89 | (2) |
|
|
91 | (5) |
|
|
96 | (13) |
|
|
109 | (3) |
|
|
112 | (5) |
|
|
117 | (57) |
|
|
174 | (24) |
|
Terbinafine hydrochloride |
|
|
198 | (17) |
|
|
215 | |
|
|
|
Amitriptyline hydrochloride |
|
|
9 | (22) |
|
|
31 | (5) |
|
|
36 | (5) |
|
|
41 | (5) |
|
Clomipramine hydrochloride |
|
|
46 | (15) |
|
Cyproheptadine hydrochloride |
|
|
61 | (11) |
|
Diphenhydramine hydrochloride |
|
|
72 | (3) |
|
|
75 | (13) |
|
Fexofenadine hydrochloride |
|
|
88 | (12) |
|
Hydroxyzine hydrochloride/palmoate |
|
|
100 | (28) |
|
|
128 | (49) |
|
Trimeprazine tartrate + prednisolone |
|
|
177 | |
|
|
|
|
4 | (46) |
|
|
50 | (6) |
|
|
56 | (6) |
|
|
62 | (14) |
|
|
76 | (7) |
|
|
83 | (15) |
|
Hydroxychloroquine sulfate |
|
|
98 | (48) |
|
Minocycline hydrochloride |
|
|
146 | (11) |
|
|
157 | (12) |
|
|
169 | (2) |
|
|
171 | (2) |
|
PO7P (Chinese herbal supplement) |
|
|
173 | (22) |
|
|
195 | (1) |
|
|
196 | (3) |
|
Tetracycline hydrochloride |
|
|
199 | |
|
Anti-inflammatory Agents, Glucocorticoids |
|
|
|
|
64 | (77) |
|
Methylprednisolone/methylprednisolone acetate |
|
|
141 | (36) |
|
|
177 | (29) |
|
|
206 | |
|
Trimeprazine tartrate + prednisolone |
|
|
177 | |
|
Antineoplastic/chemotherapeutic Agents |
|
|
|
|
32 | (22) |
|
|
54 | (72) |
|
|
126 | (9) |
|
|
135 | (36) |
|
|
171 | (33) |
|
|
204 | |
|
|
|
|
73 | (42) |
|
|
115 | (16) |
|
Lufenuron ± milbemycin oxime |
|
|
131 | (7) |
|
|
138 | (7) |
|
|
145 | (6) |
|
|
151 | (8) |
|
|
159 | (23) |
|
|
182 | (5) |
|
Sodium stibogluconate/sodium antimony gluconate |
|
|
187 | (3) |
|
Spinosad ± milbemycin oxime |
|
|
190 | |
|
|
|
|
3 | (84) |
|
|
87 | (45) |
|
|
132 | (24) |
|
Behavior Modifying Drugs, Opioid Antagonists |
|
|
|
|
156 | |
|
Behavior Modifying Drugs, Selective Serotonin Reuptake Inhibitors |
|
|
|
|
93 | (74) |
|
|
167 | (19) |
|
|
186 | |
|
Behavior Modifying Drugs, Tricyclic Antidepressants |
|
|
|
Amitriptyline hydrochloride |
|
|
9 | (37) |
|
Clomipramine hydrochloride |
|
|
46 | (29) |
|
|
75 | |
|
|
|
|
52 | (1) |
|
|
53 | (11) |
|
|
64 | (58) |
|
|
122 | (15) |
|
|
137 | (2) |
|
|
139 | (2) |
|
Methylprednisolone/methylprednisolone acetate |
|
|
141 | (3) |
|
|
144 | (4) |
|
|
148 | (2) |
|
|
150 | (27) |
|
|
177 | (7) |
|
|
184 | (4) |
|
|
188 | (13) |
|
|
201 | (1) |
|
Thyrotropin-releasing hormone |
|
|
202 | (4) |
|
|
206 | (2) |
|
|
208 | |
|
Immunomodulatory Agents, Immunostimulant |
|
|
|
Interferon alpha, recombinant human |
|
|
103 | (2) |
|
Interferon" gamma, recombinant canine |
|
|
105 | (2) |
|
Interferon omega, recombinant feline |
|
|
107 | (14) |
|
|
121 | (59) |
|
Propionibacterium acnes injection |
|
|
180 | (11) |
|
|
191 | |
|
Immunomodulatory Agents, Immunosuppressive |
|
|
|
|
15 | (1) |
|
|
16 | (2) |
|
|
18 | (14) |
|
|
32 | (22) |
|
|
54 | (2) |
|
|
56 | (8) |
|
|
64 | (38) |
|
Immunoglobulin, human intravenous (hIVIG) |
|
|
102 | (18) |
|
|
120 | (21) |
|
Methylprednisolone/methylprednisolone acetate |
|
|
141 | (13) |
|
|
154 | (23) |
|
|
177 | |
|
Neuropathic, Analgesic Agent |
|
|
|
|
95 | |
|
|
|
|
8 | (75) |
|
|
83 | (134) |
|
|
217 | |
|
|
|
|
1 | (109) |
|
|
110 | |
|
Tranquilizers, CNS Depressants, Benzodiazepines |
|
|
|
|
6 | (43) |
|
|
49 | (18) |
|
|
67 | (62) |
|
|
129 | (37) |
|
|
166 | |
|
|
|
|
22 | (190) |
|
|
212 | (2) |
|
|
214 | (5) |
|
|
|
Antipruritic Agents, Non-corticosteroid |
|
|
|
Aluminum acetate solution (Burow's solution) |
|
|
219 | (2) |
|
|
221 | (3) |
|
Diphenhydramine hydrochloride |
|
|
224 | (1) |
|
|
225 | (2) |
|
|
227 | (1) |
|
|
228 | (3) |
|
|
|
|
|
|
231 | (3) |
|
|
234 | (5) |
|
|
239 | (3) |
|
|
242 | (1) |
|
Mometasone furoate monohydrate |
|
|
243 | (3) |
|
|
246 | (3) |
|
|
|
|
249 | (4) |
|
Phytosphingosine salicyloyl |
|
|
253 | (2) |
|
|
|
|
|
|
255 | (2) |
|
|
257 | (1) |
|
|
258 | (2) |
|
|
260 | (2) |
|
|
262 | (2) |
|
|
264 | (3) |
|
Mupirocin (pseudomonic acid) |
|
|
267 | (1) |
|
|
268 | (2) |
|
|
270 | (1) |
|
Three point enzyme system |
|
|
271 | (2) |
|
|
|
|
273 | (8) |
|
|
281 | (2) |
|
|
283 | (1) |
|
|
284 | (3) |
|
|
287 | (2) |
|
|
289 | (1) |
|
|
|
|
290 | (3) |
|
|
293 | (2) |
|
|
295 | (4) |
|
Lime sulfur (sulfurated lime solution) |
|
|
299 | (2) |
|
|
301 | (3) |
|
|
304 | (3) |
|
|
307 | (2) |
|
Terbinafine hydrochloride |
|
|
309 | (1) |
|
|
|
Phytosphingosine hydrochloride |
|
|
310 | (1) |
|
|
311 | (3) |
|
|
314 | (3) |
|
|
317 | (2) |
|
|
|
|
319 | (2) |
|
|
321 | (1) |
|
|
322 | (2) |
|
|
|
Adapalene (retinoid analog) |
|
|
324 | (1) |
|
|
325 | (1) |
|
Tretinoin (all-trans retinoic acid; vitamin A acid) |
|
|
326 | (1) |
|
|
|
|
327 | (4) |
|
|
331 | (1) |
|
Dinotefuran + pyriproxyfen, ± permethrin |
|
|
331 | (2) |
|
Fipronil ± (S)-methoprene |
|
|
333 | (3) |
|
Imidacloprid combinations |
|
|
336 | (4) |
|
(S)-Methoprene combinations |
|
|
340 | (7) |
|
Permethrin and permethrin combinations |
|
|
347 | (3) |
|
|
350 | (2) |
|
|
352 | (4) |
|
Pyriproxyfen combinations |
|
|
356 | (4) |
|
|
360 | (1) |
|
|
360 | (1) |
|
|
|
|
361 | (3) |
|
|
364 | (1) |
|
|
365 | (2) |
|
|
367 | (2) |
|
|
|
|
369 | (1) |
|
|
369 | (5) |
|
|
374 | (2) |
|
|
376 | (3) |
|
|
379 | (2) |
|
Antibiotic potentiating agents |
|
|
381 | (1) |
|
Corticosteroid preparations |
|
|
382 | (1) |
|
Antibacterial preparations |
|
|
383 | (1) |
|
|
384 | (1) |
|
Corticosteroid + antimicrobial preparations |
|
|
385 | (3) |
|
Antiparasitic preparations |
|
|
388 | (3) |
|
Compounded antibiotic preparations |
|
|
391 | (4) |
|
Section 3 Allergen-Specific Immunotherapy |
|
|
|
|
395 | (10) |
|
|
395 | (1) |
|
|
395 | (1) |
|
Precautions and contraindications |
|
|
396 | (1) |
|
|
396 | (1) |
|
Time to efficacy and duration of therapy |
|
|
397 | (1) |
|
|
397 | (1) |
|
|
398 | (1) |
|
Allergen vials and treatment protocols |
|
|
399 | (2) |
|
|
401 | (1) |
|
Concurrent therapy and drug interactions |
|
|
402 | (1) |
|
|
402 | (1) |
|
Recheck evaluations and monitoring |
|
|
403 | (2) |
|
Section 4 Skin Diseases and Suggested Treatment |
|
|
|
Hypersensitivity Disorders |
|
|
|
|
405 | (1) |
|
Feline mosquito-bite hypersensitivity |
|
|
406 | (1) |
|
|
406 | (1) |
|
|
|
Discoid lupus erythematosus |
|
|
407 | (1) |
|
|
407 | (1) |
|
Sterile Inflammatory/Immune-Mediated Skin Diseases |
|
|
|
|
408 | (1) |
|
Idiopathic sterile pyogranulomatous-granulomatous syndrome |
|
|
408 | (1) |
|
|
409 | (1) |
|
|
409 | (1) |
|
|
409 | (1) |
|
Sterile nodular panniculitis |
|
|
410 | (1) |
|
|
|
|
410 | (1) |
|
|
411 | (1) |
|
|
411 | (1) |
|
|
412 | (1) |
|
Otodectic mange (otoacariosis) |
|
|
412 | (1) |
|
|
|
|
412 | (1) |
|
|
413 | (1) |
|
|
413 | (1) |
|
|
|
|
414 | (1) |
|
Canine hyperadrenocorticism |
|
|
414 | (1) |
|
|
415 | (1) |
|
|
|
|
415 | (1) |
|
Canine zinc-responsive dermatosis |
|
|
416 | (1) |
|
|
|
|
416 | (1) |
|
|
417 | (1) |
|
|
|
|
418 | (1) |
|
Canine familial dermatomyositis |
|
|
418 | (1) |
|
|
419 | (1) |
|
Canine symmetrical onychodystrophy |
|
|
419 | (1) |
|
Feline eosinophilic granuloma complex |
|
|
420 | (1) |
|
Feline psychogenic alopecia |
|
|
420 | (3) |
References |
|
423 | (12) |
Index |
|
435 | |